3. Antoni MH. Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun 2013;30:S88–S98.
4. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006;24:5132–5137.
5. Cassileth BR, Lusk EJ, Strouse TB, Miller DS, Brown LL, Cross PA. A psychological analysis of cancer patients and their next-of-kin. Cancer 1985;55:72–76.
6. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002;20:3137–3148.
7. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:57–71.
8. van’t Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 1997;59:280–293.
9. Nasreldin M, Mostafa A, Raafat O, Azim SA, ElBatrawy M, Arafa M, et al. Psychotherapeutic intervention during radiotherapy: effects on emotional and physical symptoms. Middle East Curr Psychiatry 2012;19:200–205.
10. Steel GG, McMillan TJ, Peacock JH. The 5Rs of radiobiology. Int J Radiat Biol 1989;56:1045–1048.
11. Shimotsu S, Karasawa K, Kawase E, Ito K, Saito AI, Izawa H, et al. An investigation of anxiety about radiotherapy deploying the Radiotherapy Categorical Anxiety Scale. Int J Clin Oncol 2010;15:457–461.
12. Peck A, Boland J. Emotional reactions to radiation treatment. Cancer 1977;40:180–184.
13. Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol 2005;6:520–528.
15. Sehlen S, Hollenhorst H, Schymura B, Herschbach P, Aydemir U, Firsching M, et al. Psychosocial stress in cancer patients during and after radiotherapy. Strahlenther Onkol 2003;179:175–180.
16. Holland JC, Rowland J, Lebovits A, Rusalem R. Reactions to cancer treatment: assessment of emotional response to adjuvant radiotherapy as a guide to planned intervention. Psychiatr Clin North Am 1979;2:347–358.
18. Katz S. The science of quality of life. J Chronic Dis 1987;40:459–463.
19. Lee SY, Choi SJ, Na YH. A review of the health-related quality of life. J Neurogastroenterol Motil 2001;7:6–17.
20. Frick E, Tyroller M, Panzer M. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care 2007;16:130–136.
23. de Graeff A, de Leeuw JRJ, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 2000;22:398–407.
24. Meeske KA, Patel SK, Palmer SN, Nelson MB, Parow AM. Factors associated with health-related quality of life in pediatric cancer survivors. Pediatr Blood Cancer 2007;49:298–305.
25. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–376.
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571.
27. Sung H, Kim J, Park Y, Bai D, Lee S, Ahn H. A study on the reliability and the validity of Korean version of the Beck Depression Inventory-II (BDI-II). J Korean Soc Biol Ther Psychiatry 2008;14:201–212.
28. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–897.
29. Kwon S. Assessment of psychopathology in anxiety disorder. Korean J Psychopathol 1997;6:37–51.
30. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–396.
31. Park JO, Seo YS. Validation of the perceived stress scale (PSS) on samples of Korean university students. Korean J Psychol 2010;29:611–629.
32. Jon BJ. Self-esteem: a test of its measurability. Yonsei Collection of writings 1974;11:107–130.
33. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson resilience scale (CD-RISC). Depress Anxiety 2003;18:76–82.
34. Jung YE, Min JA, Shin AY, Han SY, Lee KU, Kim TS, et al. The Korean version of the Connor-Davidson Resilience Scale: an extended validation. Stress Health 2012;28:319–26.
35. Lubben JE. Assessing social networks among elderly populations. Fam Commun Health 1988;11:42–52.
36. Lee KW, Kim SY, Chung W, Hwang GS, Hwang YW, Hwang IH. The validity and reliability of Korean version of lubben social network scale. Korean J Fam Med 2009;30:352–358.
37. Jung YE, Chae JH. A review of resilience assessment tools. J Korean Neuropsychiatr Assoc 2010;49:50–57.
38. Min JA, Yoon S, Lee CU, Chae JH, Lee C, Song KY, et al. Psychological resilience contributes to low emotional distress in cancer patients. Support Care Cancer 2013;21:2469–2476.
39. Ye ZJ, Qiu HZ, Li PF, Liang MZ, Zhu YF, Zeng Z, et al. Predicting changes in quality of life and emotional distress in Chinese patients with lung, gastric, and colon-rectal cancer diagnoses: the role of psychological resilience. Psychooncology 2017;26:829–835.
40. Molina Y, Yi JC, Martinez-Gutierrez J, Reding KW, Yi-Frazier JP, Rosenberg AR. Resilience among patients across the cancer continuum: diverse perspectives. Clin J Oncol Nurs 2014;18:93–101.
41. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract 2015;11:145–150.
42. Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 2014;10:332–338.
43. Gupta D, Lis CG, Grutsch JF. Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer 2007;15:1051–1056.
44. Brooks J, Wilson K, Amir Z. Additional financial costs borne by cancer patients: a narrative review. Eur J Oncol Nurs 2011;15:302–310.
45. Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest 2007;25:47–54.
46. Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public‒private healthcare system. Support Care Cancer 2013;21:107–117.
48. Zafar SY. Financial toxicity of cancer care: It’s time to intervene. J Natl Cancer Inst 2015;108:djv370
49. Yang D, Kim H, Kang E, Kim D, Bae E, Kim J. Patterns and determinants of catastrophic health expenditure in the households with cancer patients. Korean J Health Econ Policy 2017;23:53–70.
50. Chin YR, Lee IS, Lee HY. Effects of hypertension, diabetes, and/or cardiovascular disease on health-related quality of life in elderly Korean individuals: a population-based cross-sectional survey. Asian Nurs Res 2014;8:267–273.
51. Bardage C, Isacson DG. Hypertension and health-related quality of life: an epidemiological study in Sweden. J Clin Epidemiol 2001;54:172–181.
52. Naeim A, Dy SM, Lorenz KA, Sanati H, Walling A, Asch SM. Evidencebased recommendations for cancer nausea and vomiting. J Clin Oncol 2008;26:3903–3910.
53. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer 2004;12:246–252.
54. Ravasco P, Monteiro-Grillo I, Camilo ME. Does nutrition influence quality of life in cancer patients undergoing radiotherapy? Radiother Oncol 2003;67:213–220.
55. Mantovani G, MacciÒ A, Massa E, Madeddu C. Managing cancer-related anorexia/cachexia. Drugs 2001;61:499–514.